Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results (Q42269134)
Jump to navigation
Jump to search
scientific article published on 26 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results |
scientific article published on 26 March 2013 |
Statements
1 reference
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results (English)
1 reference
Joel E Gallant
1 reference
Ellen Koenig
1 reference
Jaime Andrade-Villanueva
1 reference
Ploenchan Chetchotisakd
1 reference
Edwin DeJesus
1 reference
Francisco Antunes
1 reference
Keikawus Arastéh
1 reference
Graeme Moyle
1 reference
Giuliano Rizzardini
1 reference
Jan Fehr
1 reference
Yapei Liu
1 reference
Lijie Zhong
1 reference
Christian Callebaut
1 reference
Javier Szwarcberg
1 reference
Martin S Rhee
1 reference
Andrew K Cheng
1 reference
26 March 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference